Author

R. J. Wolsky

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell-cell communication· 1 Approach:experimental assay· 1 Approach:machine learning (classical)· 1 Research Focus:spatial domain detection· 1 Assay:spatial transcriptomics· 1 Approach:statistical model· 1

Frequent Co-Authors

B. G. Bitler· 2 shared A. Clauset· 1 shared B. R. Corr· 1 shared C. Bailey· 1 shared C. Rickert· 1 shared E. R. Woodruff· 1 shared J. Hu· 1 shared J. K. Richer· 1 shared

Activity by Year

2023-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

B. G. Bitler

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivJan 26, 2024

The spatial structure of the tumor immune microenvironment can explain and predict patient response in high-grade serous carcinoma

L. B. Van Kleunen, M. Ahmadian, M. D. Post…·A. Clauset

The paper uses spatial data from ovarian cancer tumors to show that spatial organization of the immune microenvironment correlates with patient outcomes and can predict treatment response.

DOI 10.1158/2326-6066.cir-23-1109

humanspatial transcriptomics

𝕏 PostBluesky

Cancer BiologybioRxivPreprintApr 4, 2023

Combination CDC-like kinase inhibition (CLK)/Dual-specificity tyrosine-regulated kinase (DYRK) and taxane therapy in CTNNB1-mutated endometrial cancer

B. R. Corr, M. R. Moroney, E. R. Woodruff…·B. G. Bitler

This paper evaluates SM08502, a CLK/DYRK inhibitor, as a single-agent and in combination with paclitaxel for CTNNB1-mutated endometrial cancer, showing synergistic effects and tumor volume reduction in vitro and in vivo.

DOI 10.1101/2023.04.04.535570

humanexperimental assay

𝕏 PostBluesky